Urolithiasis is a common malady afflicting 8.8% of the general population. Its occurrence is also not uncommon in patients undergoing renal replacement therapy. Despite the leaping scientific advancement achieved in managing and preventing urolithiasis in the general population, there remains limited data regarding its prevention in patients undergoing renal replacement therapy.
We present a case of recurrent urolithiasis in a patient with end-stage renal disease on renal replacement therapy.
We performed a literature review on urolithiasis in patients with ESKD undergoing renal replacement therapy, emphasizing evidence-based available preventative strategies.
Hemodialysis international. International Symposium on Home Hemodialysis. 2025 Mar 04 [Epub ahead of print]
Parasto Asnaashari, Pran M Kar, Saif Borgan, Olga Karasik
University of Central Florida, HCA Florida Healthcare, Orlando, Florida, USA., Department of Internal Medicine, University of Central Florida College of Medicine, Orlando, Florida, USA., Department of Medicine, South Georgia Medical Center, Valdosta, Georgia, USA.